India: number of patented products in cardiac segment by leading company 2020

Number of patented products in cardiac market in India from financial year 2018 to 2020, by leading company

Number of patented products in cardiac market India FY 2018-2020, by leading company

Last update:

Feb 8, 2021

Author:

��ƽ�� Research Department

Region:

India

Survey time period:

From 01/01/2018 to 31/12/2020

The pharmaceutical company Novartis had about 1,234 patents in the cardiac segment under the brand name Vymada as of financial year 2020 in India. The brand was launched in February 2017 and its earliest patent expiry is in 2023.

We’re happy to help

Get in touch with us for additional information

Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.

Get in touch

�����ƽ��

Number of patented products in cardiac market in India from financial year 2018 to 2020, by leading company

Get in touch with us for additional information

��ƽ��